[F-18]Fluorodeoxyglucose Positron Emission Tomography Can Predict Pathological Tumor Stage and Proliferative Activity Determined by Ki-67 in Clinical Stage IA Lung Adenocarcinomas

TNM Classification of Malignant Tumours

1987 • 16,209 citations

Prognostic and predictive factors in breast cancer by immunohistochemical analysis.

1998 • 2,121 citations

Combining independent studies of a diagnostic test into a summary roc curve: Data‐analytic approaches and some additional considerations

1993 • 1,358 citations

Accuracy of Positron Emission Tomography for Diagnosis of Pulmonary Nodules and Mass Lesions

2001 • 1,095 citations

Preoperative Chemotherapy Followed by Surgery Compared With Primary Surgery in Resectable Stage I (Except T1N0), II, and IIIa Non–Small-Cell Lung Cancer

2002 • 568 citations

Prospective investigation of positron emission tomography in lung nodules.

1998 • 557 citations

Prognostic Importance of the Standardized Uptake Value on ¹⁸F-Fluoro-2-Deoxy-Glucose–Positron Emission Tomography Scan in Non–Small-Cell Lung Cancer: An Analysis of 125 Cases

1999 • 442 citations

Influence of the blood glucose concentration on FDG uptake in cancer--a PET study.

1993 • 404 citations

The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification?

1994 • 394 citations

Lung cancer proliferation correlates with [F-18]fluorodeoxyglucose uptake by positron emission tomography.

2000 • 354 citations

The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma

1998 • 335 citations

Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images

2004 • 334 citations

Diagnostic Efficacy of PET-FDG Imaging in Solitary Pulmonary Nodules

1993 • 329 citations

Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET.

1996 • 314 citations

Prognostic significance of p53 alterations in patients with non-small cell lung cancer: a meta-analysis.

2000 • 300 citations

Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysis

2004 • 265 citations

Lymph node involvement, recurrence, and prognosis in resected small, peripheral, non-small-cell lung carcinomas: Are these carcinomas candidates for video-assisted lobectomy?

1996 • 259 citations

Standardized uptake values of FDG: body surface area correction is preferable to body weight correction.

1994 • 234 citations

FDG PET measurement of the proliferative potential of non-small cell lung cancer.

2000 • 173 citations

T1 Lung Cancers: Sensitivity of Diagnosis with Fluorodeoxyglucose PET

2002 • 154 citations

Positron emission tomography with 18F-FDG to detect residual disease after therapy for malignant lymphoma

1998 • 144 citations

Evaluation of immunohistochemical markers in non-small cell lung cancer by unsupervised hierarchical clustering analysis: a tissue microarray study of 284 cases and 18 markers

2004 • 129 citations

Cyclin D1, p16 and retinoblastoma gene product expression as a predictor for prognosis in non-small cell lung cancer at stages I and II

2001 • 114 citations

Visual and Semiquantitative Analyses for F-18 Fluorodeoxyglucose PET Scanning in Pulmonary Nodules 1 cm to 3 cm in Size

2005 • 103 citations

The size of metastatic foci and lymph nodes yielding false-negative and false-positive lymph node staging with positron emission tomography in patients with lung cancer

2004 • 103 citations

Validation of FDG positron emission tomography for differentiation of unknown pulmonary lesions

2001 • 62 citations

Evaluation of various corrections to the standardized uptake value for diagnosis of pulmonary malignancy

2001 • 57 citations

Fluorine 18–tagged fluorodeoxyglucose positron emission tomographic scanning to predict lymph node metastasis, invasiveness, or both, in clinical T1 N0 M0 lung adenocarcinoma

2004 • 44 citations

Histogram analysis of computed tomography numbers of clinical T1 N0 M0 lung adenocarcinoma, with special reference to lymph node metastasis and tumor invasiveness

2003 • 43 citations

Prognostic Impact of Survivin, Cyclin D1, Integrin β1, and VEGF in Patients With Small Adenocarcinoma of Stage I Lung Cancer

2004 • 25 citations

Alterations of tumor suppressor genes (Rb, p16, p27 and p53) and an increased FDG uptake in lung cancer

2003 • 24 citations

Prognostic significance of p21waf1, cyclin D1 and retinoblastoma expression detected by immunohistochemistry in non-small cell lung cancer

2001 • 11 citations